Search

everythinglearnresearchcommunity

for

Search:↓

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

FDG PET/CT scans can change cancer treatment plans for dogs.

Indian Hedgehog helps control skin cell growth and protects against aggressive skin cancer.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

The study concluded that careful examination is key to differentiate between lipidized fibrous histiocytoma and juvenile xanthogranuloma.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Adding a second method to PROTACs could improve cancer treatment.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Targeting colon cancer stem cells might lead to better treatment results.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

PLD is an effective and safer alternative for treating breast cancer.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Thymosin β4 promotes hair growth by activating stem cells in hair follicles.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.